Nice | Alzheimer’s drugs

This is a guideline update from NICE on the use of  donepezil, galantamine, rivastigmine and memantine in Alzheimer's disease.

Donepezil, galantamine and rivastigmine (the acetylcholinesterase - AChE - inhibitors) can now be used in mild disease, as well as in moderate disease. These drugs all work by increasing the level of ACh at sites of neurotransmission.

Memantine can be used in moderate disease if patients can't take AChE inhibitors. It can also be used in severe disease. Memantine is a (wait for it!)  voltage-dependent, moderate-affinity, uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist. Basically, there are increased levels of glutamate seen at neurotransmitter sites. Memantine blocks the effects of this increased glutamate.

Conditions for use

  • Specialist use only
  • They should only be continued of there is improvement in cognition or global, functional or behavioural symptoms.
  • For AChE inhibitors, taking into account individual needs, the lowest acquisition drug should be used.

Louise Hudman

I'm a freelance GP locum in Winchester & Southampton locum chambers, and Pallant Medical Chambers Clinical Guidelines Lead Partner.

Use the NASGP CPD templates to record your reflections.

No Comments Yet.

Leave your comments